![](https://www.fdanews.com/ext/resources/test/Drug-Images3/gavel_with_shadow.jpg?t=1435080640&width=430)
Former GSK Employee Sues Drugmaker
A former GlaxoSmithKline employee has filed suit against his former employer, alleging the drugmaker terminated him for blowing the whistle on alleged mistakes during clinical trials of NiQuintin oral strips.
Alexandre Selmani, who worked as a manager of biostatistics, alerted company executives of several errors in the statistical methodology of the Phantom Patch study, which affected the quality of the project, according to the lawsuit filed in the Superior Court of New Jersey in Morris County. The plaintiff says GSK’s claims that NiQuintin is a “significant advance” in helping battle nicotine addiction is deceptive.
GSK spokeswoman Pamela McKinlay says the company has not yet been served with a legal summons and that it stands behind NiQuintin as a safe and effective form of smoking cessation. Read the lawsuit here: www.fdanews.com/01-08-16-GSKlawsuit.pdf.